News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Advertise
Talent Solutions
Post Jobs
Submit a Press Release
Submit an Event
Search Query
Submit Search
Takeda Pharmaceutical Co. Ltd. Introduces New Measles-Rubella Vaccine
January 31, 2006
|
1 min read
Twitter
LinkedIn
Facebook
Email
Print
Tokyo, Jan 31, 2006 (JCN) - Takeda Pharmaceutical announced on January 30 that it has launched Takeda, its proprietary measles-rubella (MR) vaccine.
Twitter
LinkedIn
Facebook
Email
Print
Asia
Takeda
MORE ON THIS TOPIC
Funding
RA Capital Looks to China for Next Startup To Put on SPAC Track to Nasdaq
March 25, 2026
·
2 min read
·
Tristan Manalac
Manufacturing
Novartis Pledges $480M To Expand China Presence, Following Eli Lilly and AstraZeneca
March 24, 2026
·
2 min read
·
Nick Paul Taylor
Opinion
Japan’s Drug Prices Are Creating Problems for Washington and Tokyo Alike
March 24, 2026
·
4 min read
·
John Stanford
Manufacturing
AstraZeneca Building Shanghai Production Plant to Support Cell Therapy Strategy
March 19, 2026
·
2 min read
·
Nick Paul Taylor
